Trial Profile
A pharmacokinetic and tolerability phase I study to evaluate the effect of vinflunine in cancer patients with renal impairment.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2015
Price :
$35
*
At a glance
- Drugs Vinflunine (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- 09 Nov 2015 New trial record